Landscape Dashboard
Analyze the gene-editing trial field
Scan API-backed trial records by phase, status, disease, editing method, delivery method, geography, and recent updates.
Loading dashboard data...
Registry matches
8
ClinicalTrials.gov result count
Loaded sample
8
Records analyzed below
Recruiting
4
Open or actively enrolling
In vivo
1
Delivered directly in body
Trials by phase
Where studies sit in the clinical pipeline.
Trials by status
Recruiting and active trial availability.
Editing methods
Modality breakdown across selected records.
Delivery methods
How edited therapies are delivered.
Disease areas
Conditions represented in the current trial set.
Geographic footprint
High-level location grouping for trial records.
Landscape readout
Delivery patterns are split across modalities.
The loaded sample separates cell-based ex vivo programs from direct in vivo approaches such as AAV and lipid nanoparticle delivery.
5
ex vivo records
3
delivery categories
Recently updated trials
Most recent records in the current local trial set.
| NCT ID | Trial | Status | Updated |
|---|---|---|---|
| NCT05687110 | Base Edited Hematopoietic Stem Cells for Sickle Cell Disease Sickle Cell Disease - HBG1/HBG2 | Recruiting | 2026-05-10 |
| NCT04925206 | Autologous CRISPR-Edited T Cells for Relapsed Leukemia Acute Lymphoblastic Leukemia - PDCD1 | Recruiting | 2026-05-02 |
| NCT06025084 | In Vivo CRISPR Therapy for Transthyretin Amyloidosis Transthyretin Amyloidosis - TTR | Recruiting | 2026-04-26 |
| NCT03745287 | CRISPR-Cas9 Therapy for Severe Sickle Cell Disease Sickle Cell Disease - BCL11A | Recruiting | 2026-04-18 |
| NCT04208529 | CRISPR-Modified Immune Cells for Solid Tumors Solid Tumor - TRAC | Active | 2026-04-07 |